Enteral Nutrition Support for Adult Patients with Fat Malabsorption

Enteral Nutrition Support for Adult Patients with Fat Malabsorption

Issue link: https://eguideline.guidelinecentral.com/i/1289696

Contents of this Issue

Navigation

Page 9 of 15

10 Enteral Nutrition Options in the Patient with Fat Malabsorption Table 8. Oral Pancreatic Enzymes & Dosage Units Form Product Manufacturer Lipase units* Enteric-coated capsule contents (acid suppression may be required if the pancreas is so compromised that bicarbonate secretion is diminished or absent to alkalinize gastric secretion from the stomach) Creon AbbVie • 3000 • 6000 • 12,000 • 24,000 • 36,000 Pancreaze Vivus • 2600 • 4200 • 10,500 • 16,800 • 21,000 Pertzye Digestive Care, Inc • 4000 • 8000 • 16,000 • 24,000 Zenpep Nestlé Health Science • 3000 • 5000 • 10,000 • 15,000 • 20,000 • 25,000 • 40,000 Non-enteric coated tablet (acid suppression is required) Viokace Nestlé Health Science • 10,440 • 20,880 Notes: • Although oral pancreatic enzymes also include protease and amylase, clinicians typically dose based on lipase units. • Oral pancreatic enzymes are derived from porcine sources and should be used with caution in individuals with pork allerg y.

Articles in this issue

view archives of Enteral Nutrition Support for Adult Patients with Fat Malabsorption - Enteral Nutrition Support for Adult Patients with Fat Malabsorption